COMP360 for Treatment-Resistant Depression: Insights on New Phase 3 Trials From Guy Goodwin, MD

Thursday, March 12, 2026

AI Briefing

COMP360, depression, treatment-resistant, Phase 3 trials, Guy Goodwin, MD, new insights